Heidelberger passed muster, and in September 1912 began working in Walter Abraham Jacobs' laboratory on a derivative of hexamethylene tetramine, a complex that seemed to prolong the life of monkeys suffering from polio, and that Flexner hoped could be adapted for use in humans.